Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

Levin, E. G., Lustig, Y., Cohen, C., Fluss, R., Indenbaum, V., Amit, S., Doolman, R., Asraf, K., Mendelson, E., Ziv, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114583 · Cited by 1,703

Evolution of antibody immunity to SARS-CoV-2

Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674

A guide to vaccinology: from basic principles to new developments

Pollard, A. J., & Bijker, E. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00479-7 · Cited by 1,593

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

Bergwerk, M., Gonen, T., Lustig, Y., Amit, S., Lipsitch, M., Cohen, C., Mandelboim, M., Levin, E. G., Rubin, C., Indenbaum, V., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2109072 · Cited by 1,345

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Wang, Z., Schmidt, F., Weisblum, Y., Muecksch, F., Barnes, C. O., Finkin, S., Schaefer-Babajew, D., Cipolla, M., Gaebler, C., Lieberman, J. A., et al. (2021) · Nature · doi:10.1038/s41586-021-03324-6 · Cited by 1,343

Humoral Immunity Due to Long-Lived Plasma Cells

Slifka, M. K., Antia, R., Whitmire, J. K., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80541-5 · Cited by 1,249

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Bar-On, Y. M., Goldberg, Y., Mandel, M., Bodenheimer, O., Freedman, L., Kalkstein, N., Mizrahi, B., Alroy-Preis, S., Ash, N., Milo, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114255 · Cited by 1,169

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Sterlin, D., Mathian, A., Miyara, M., Mohr, A., Anna, F., Claër, L., Quentric, P., Fadlallah, J., Devilliers, H., Ghillani, P., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd2223 · Cited by 1,037

Waning Immunity after the BNT162b2 Vaccine in Israel

Goldberg, Y., Mandel, M., Bar-On, Y. M., Bodenheimer, O., Freedman, L., Haas, E. J., Milo, R., Alroy-Preis, S., Ash, N., & Huppert, A. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114228 · Cited by 1,034

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., et al. (2021) · Science · doi:10.1126/science.abm0829 · Cited by 873

Adaptive Immune Responses and Immunity to SARS-CoV-2

Primorac, D., Vrdoljak, K., Brlek, P., Pavelić, E., Molnar, V., Matišić, V., Ivkošić, I. E., & Parčina, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.848582 · Cited by 162

SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic

Bertoletti, A., Bert, N. L., & Tan, A. T. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.008 · Cited by 117

SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity

Lim, J. M. E., Tan, A. T., Bert, N. L., Hang, S. K., Low, J. G. H., & Bertoletti, A. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220780 · Cited by 115

Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study

Gazit, S., Saciuk, Y., Perez, G., Peretz, A., Pitzer, V. E., & Patalon, T. (2022) · BMJ · doi:10.1136/bmj-2022-071113 · Cited by 87

Mucosal plasma cells are required to protect the upper airway and brain from infection

Wellford, S. A., Moseman, A. P., Dao, K., Wright, K., Chen, A. P., Plevin, J. E., Liao, T.-C., Mehta, N. U., & Moseman, E. A. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.017 · Cited by 75

Defending against SARS-CoV-2: The T cell perspective

Almendro-Vázquez, P., Laguna‐Goya, R., & Paz‐Artal, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1107803 · Cited by 67

SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease

Wagner, A., Garner‐Spitzer, E., Schötta, A., Orola, M. J., Wessely, A., Zwazl, I., Ohradanova‐Repic, A., Weseslindtner, L., Tajti, G., Gebetsberger, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.889138 · Cited by 58

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose

Rénia, L., Goh, Y. S., Rouers, A., Bert, N. L., Chia, W. N., Chavatte, J., Fong, S., Chang, Z. W., Zhuo, N. Z., Tay, M. Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32312-1 · Cited by 62

SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection

Pušnik, J., Monzon‐Posadas, W. O., Zorn, J., Peters, K., Baum, M., Proksch, H., Schlüter, C. B., Alter, G., Menting, T., & Streeck, H. (2023) · Nature Communications · doi:10.1038/s41467-023-36250-4 · Cited by 53

Olfactory immunology: the missing piece in airway and CNS defence

Wellford, S. A., & Moseman, E. A. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00972-9 · Cited by 53

Variations within the Glycan Shield of SARS-CoV-2 Impact Viral Spike Dynamics

Newby, M. L., Fogarty, C. A., Allen, J. D., Butler, J., Fadda, E., & Crispin, M. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167928 · Cited by 48

Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70

Brook, B., Duval, V., Barman, S., Speciner, L., Sweitzer, C., Khanmohammed, A., Menon, M., Foster, K., Ghosh, P., Abedi, K., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adm8451 · Cited by 46

AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans

Grigoryan, L., Feng, Y., Bellusci, L., Lai, L., Wali, B., Ellis, M. L., Yuan, M., Arunachalam, P. S., Hu, M., Kowli, S., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adi8039 · Cited by 43

Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study

Fedele, G., Trentini, F., Schiavoni, I., Abrignani, S., Antonelli, G., Baldo, V., Baldovin, T., Bandera, A., Bonura, F., Clerici, P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1021396 · Cited by 39

The past, current and future epidemiological dynamic of SARS-CoV-2

Balloux, F., Tan, C. C. S., Swadling, L., Richard, D., Jenner, C., Maini, M. K., & van Dorp, L. (2022) · Oxford Open Immunology · doi:10.1093/oxfimm/iqac003 · Cited by 41

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine

Azzi, L., Gasperina, D. D., Veronesi, G., Shallak, M., Maurino, V., Baj, A., Gianfagna, F., Cavallo, P., Dentali, F., Tettamanti, L., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2022.104435 · Cited by 40

Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues

Davis‐Porada, J., George, A. B., Lam, N., Caron, D. P., Gray, J. I., Huang, J., Hwu, J., Wells, S. B., Matsumoto, R., Kubota, M., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.10.003 · Cited by 37

Olfactory immune response to SARS-CoV-2

Wellford, S. A., & Moseman, E. A. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01119-5 · Cited by 36

Specific Anti-SARS-CoV-2 Humoral and Cellular Immune Responses After Booster Dose of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine: Integrated Study of Adaptive Immune System Components

Busà, R., Sorrentino, M. C., Russelli, G., Amico, G., Miceli, V., Miele, M., Bella, M. D., Timoneri, F., Gallo, A., Zito, G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.856657 · Cited by 34

Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination

Barateau, V., Peyrot, L., Saade, C., Pozzetto, B., Brengel‐Pesce, K., Elsensohn, M., Allatif, O., Guibert, N., Compagnon, C., Mariano, N., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade0550 · Cited by 33

SARS-CoV-2 Breakthrough Infections: Incidence and Risk Factors in a Large European Multicentric Cohort of Health Workers

Porru, S., Monaco, M. G. L., Spiteri, G., Carta, A., Pezzani, M. D., Lippi, G., Gibellini, D., Tacconelli, E., Vecchia, I. D., Sala, E., et al. (2022) · Vaccines · doi:10.3390/vaccines10081193 · Cited by 30

Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa

Declercq, J., Gerlo, S., Nevel, S. V., Ruyck, N. D., Holtappels, G., Delesie, L. M., Tobback, E., Lammens, I., Gerebtsov, N., Sedeyn, K., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adn2364 · Cited by 28

Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles

Touizer, E., Alrubayyi, A., Ford, R., Hussain, N., Gerber, P. P., Shum, H.-L., Rees-Spear, C., Muir, L., Gea‐Mallorquí, E., Kopycinski, J. T., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105862 · Cited by 27

Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2

Lenart, K., Cerveira, R. A., Hellgren, F., Ols, S., Sheward, D. J., Kim, C., Cagigi, A., Gagné, M., Davis, B. J., Germosen, D., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00806-2 · Cited by 26

A highly efficacious live attenuated mumps virus–based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike

Zhang, Y., Lu, M., Mahesh, K. C., Kim, E., Shamseldin, M. M., Ye, C., Dravid, P., Chamblee, M., Park, J., Hall, J. M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2201616119 · Cited by 26

Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine

de Assis, F. L., Hoehn, K. B., Zhang, X., Kardava, L., Smith, C. D., Merhebi, O. E., Buckner, C. M., Trihemasava, K., Wang, W., Seamon, C. A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112780 · Cited by 27

Immunogenicity of SARS-CoV-2 vaccines in patients with cancer

Kakkassery, H., Carpenter, E., Patten, P., & Irshad, S. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.07.006 · Cited by 23

B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV

Polvere, J., Fabbiani, M., Pastore, G., Rancan, I., Rossetti, B., Durante, M., Zirpoli, S., Morelli, E., Pettini, E., Lucchesi, S., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00245-5 · Cited by 23

Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding

Hartley, G. E., Fryer, H. A., Gill, P. A., Boo, I., Bornheimer, S. J., Hogarth, P. M., Drummer, H. E., O’Hehir, R. E., Edwards, E. S. J., & van Zelm, M. C. (2024) · npj Vaccines · doi:10.1038/s41541-024-00919-8 · Cited by 24

Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms

Pineda-Peña, A.-C., Hasegawa, K., Pavot, V., Berry, C., Combadière, B., Cortés-Garcia, G., McDermott, A. B., & Sridhar, S. (2025) · npj Vaccines · doi:10.1038/s41541-025-01302-x · Cited by 23

The immune response as a double‐edged sword: The lesson learnt during the COVID ‐19 pandemic

Agrati, C., Carsetti, R., Bordoni, V., Sacchi, A., Quintarelli, C., Locatelli, F., Ippolito, G., & Capobianchi, M. R. (2022) · Immunology · doi:10.1111/imm.13564 · Cited by 22

Immune responses related to the immunogenicity and reactogenicity of COVID-19 mRNA vaccines

Matsumura, T., Takano, T., & Takahashi, Y. (2022) · International Immunology · doi:10.1093/intimm/dxac064 · Cited by 21

AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection

Aksyuk, A. A., Bansal, H., Wilkins, D. E., Stanley, A. M., Sproule, S., Maaske, J., Sanikommui, S., Hartman, W. R., Sobieszczyk, M. E., Falsey, A. R., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100882 · Cited by 21

Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant

Mise‐Omata, S., Ikeda, M., Takeshita, M., Uwamino, Y., Wakui, M., Arai, T., Yoshifuji, A., Murano, K., Siomi, H., Nakagawara, K., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200525 · Cited by 20

The BNT162b2 vaccine induces humoral and cellular immune memory to SARS-CoV-2 Wuhan strain and the Omicron variant in children 5 to 11 years of age

Cinicola, B. L., Mortari, E. P., Zicari, A. M., Agrati, C., Bordoni, V., Albano, C., Fedele, G., Schiavoni, I., Leone, P., Fiore, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1094727 · Cited by 20

Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic review

Guerra, E. N. S., de Castro, V. T., dos Santos, J. A., Acevedo, A. C., & Chardin, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1006040 · Cited by 18

Viral infection and antiviral immunity in the oral cavity

Hickman, H. D., & Moutsopoulos, N. M. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01100-x · Cited by 19

Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus Vaccination in Pregnancy: Implications for Maternal and Infant Immunity

Conti, M. G., Terreri, S., Terrin, G., Natale, F., Pietrasanta, C., Salvatori, G., Brunelli, R., Midulla, F., Papaevangelou, V., Carsetti, R., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac359 · Cited by 17

Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination

Qi, F., Cao, Y., Zhang, S., & Zhang, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.964976 · Cited by 16

Waning immunity and the future of booster vaccination strategies in global vaccine programs post COVID-19

Biswas, R., Roy, A., Kayal, T., Basu, S., Ghosh, S., Ramaiah, S., & Anbarasu, A. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2626088 · Cited by 15

CD62L expression marks a functionally distinct subset of memory B cells

Hanson, C. H., Henry, B., Andhare, P., Lin, F. J., Pak, H., Turner, J. S., Adams, L. J., Liu, T., Fremont, D. H., Ellebedy, A. H., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113542 · Cited by 15

Association between sex hormones and anti-S/RBD antibody responses to COVID-19 vaccines in healthcare workers

Anticoli, S., Dorrucci, M., Iessi, E., Chiarotti, F., Prinzio, R. R. D., Vinci, M. R., Zaffina, S., Puro, V., Colavita, F., Mizzoni, K., et al. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2273697 · Cited by 15

Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models

Warang, P., Singh, G., Moshir, M., Binazon, O., Laghlali, G., Chang, L. A., Wouters, H., Vanhoenacker, P., Notebaert, M., Elhemdaoui, N., et al. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2470542 · Cited by 14

T and B cell responses in different immunization scenarios for COVID-19: a narrative review

Mortari, E. P., Ferrucci, F., Zografaki, I., Carsetti, R., & Pacelli, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1535014 · Cited by 14

Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2

Monzon‐Posadas, W. O., Zorn, J., Peters, K., Baum, M., Proksch, H., Schlüter, C. B., Menting, T., Pušnik, J., & Streeck, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1066123 · Cited by 13

Durable immune responses after BNT162b2 vaccination in home-dwelling old adults

Hansen, L., Brokstad, K. A., Bansal, A., Zhou, F., Bredholt, G., Onyango, T. B., Sandnes, H. H., Elyanow, R., Madsen, A., Trieu, M.-C., et al. (2023) · Vaccine X · doi:10.1016/j.jvacx.2023.100262 · Cited by 12

The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients

Malahe, S. R. K., den Hartog, Y., Rietdijk, W. J. R., van Baarle, D., de Kuiper, R., Reijerkerk, D., Ras, A. M., Geers, D., Diavatopoulos, D. A., Messchendorp, A. L., et al. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.05.025 · Cited by 12

Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine

Ciabattini, A., Pastore, G., Lucchesi, S., Montesi, G., Costagli, S., Polvere, J., Fiorino, F., Pettini, E., Lippi, A., Ancillotti, L., et al. (2023) · Cells · doi:10.3390/cells12131706 · Cited by 12

Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein

den Hartog, G., Andeweg, S. P., Hoeve, C. E., Smits, G. P., Voordouw, B. C. G., Eggink, D., Knol, M. J., & van Binnendijk, R. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-45718-8 · Cited by 12

The gut microbiota modifies antibody durability and booster responses after SARS-CoV-2 vaccination

Seong, H., Yoon, J. G., Nham, E., Choi, Y. J., Noh, J. Y., Cheong, H. J., Kim, W. J., Kim, E. H., Kim, C., Han, Y.-H., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05637-2 · Cited by 11

Impairment of Innate Immunity and Depletion of Vaccine‐Induced Memory B and T Cells in the Absence of the Spleen

Bordoni, V., Cinicola, B. L., Mortari, E. P., Castilletti, C., Guarracino, F., Albano, C., Accordini, S., Baban, A., Sabatino, A. D., Rossi, C. M., et al. (2025) · American Journal of Hematology · doi:10.1002/ajh.27634 · Cited by 10

Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters

Mortari, E. P., Pulvirenti, F., Marcellini, V., Terreri, S., Salinas, A. F., Ferrari, S., Napoli, G. D., Guadagnolo, D., Sculco, E., Albano, C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1194225 · Cited by 10

SARS-CoV-2–specific mucosal immune response in vaccinated versus infected children

Conti, M. G., Mortari, E. P., Nenna, R., Pierangeli, A., Sorrentino, L., Frasca, F., Petrarca, L., Mancino, E., Mattia, G. D., Matera, L., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1231697 · Cited by 10

Comparison of Two Commercially Available Interferon-γ Release Assays for T-Cell-Mediated Immunity and Evaluation of Humoral Immunity against SARS-CoV-2 in Healthcare Workers

Lochmanová, A., Martínek, J., Tomášková, H., Zelená, H., Dieckmann, K., Grage‐Griebenow, E., Ježo, E., & Janošek, J. (2023) · Diagnostics · doi:10.3390/diagnostics13040637 · Cited by 10

COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants

Stefanelli, P., & Rezza, G. (2022) · Vaccines · doi:10.3390/vaccines10060905 · Cited by 10

High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium

Calcoen, B., Callewaert, N., Vandenbulcke, A., Kerstens, W., Imbrechts, M., Vercruysse, T., Dallmeier, K., Weyenbergh, J. V., Maes, P., Bossuyt, X., et al. (2022) · Viruses · doi:10.3390/v14061257 · Cited by 8

Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients

Ellis, S., Way, R., Nel, M., Burleigh, A., Doykov, I., Kembou-Ringert, J. E., Woodall, M., Masonou, T., Case, K., Ortez, A. T., et al. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.11.007 · Cited by 8

Longitudinal analysis of immune responses to SARS-CoV-2 recombinant vaccine S-268019-b in phase 1/2 prime-boost study

Fujitani, M., Lu, X., Shinnakasu, R., Inoue, T., Kidani, Y., Seki, N. M., Ishida, S., Mitsuki, S., Ishihara, T., Aoki, M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1550279 · Cited by 8

Lymphocyte Subpopulations Associated with Neutralizing Antibody Levels of SARS-CoV-2 for COVID-19 Vaccination

Huang, W., Weng, S., Tzeng, H., Yen, F.-C., Chiang, Y.-S., & You, H. (2022) · Vaccines · doi:10.3390/vaccines10091550 · Cited by 8

SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients

Chen, Y., Zhao, T., Chen, L., Jiang, G., Geng, Y., Li, W., Yin, S., Tong, X., Tao, Y., Ni, J., et al. (2024) · mBio · doi:10.1128/mbio.02407-23 · Cited by 8

Polymicrobial biofilms: biological insights and emerging directions in drug discovery

Arasu, A. (2025) · Future Microbiology · doi:10.1080/17460913.2025.2604691 · Cited by 8

The impact of vaccine hesitancy on psychological impairment among healthcare workers in a Total Worker Health© approach

Prinzio, R. R. D., Ceresi, B., Arnesano, G., Dosi, A., Maimone, M., Vacca, M. E., Vinci, M. R., Camisa, V., Santoro, A., Raponi, M., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1447334 · Cited by 6

Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic

Molinos-Albert, L. M., Rubio, R., Martín-Pérez, C., Pradenas, E., Torres, C., Jiménez, A., Canyelles, M., Vidal, M., Barrios, D., Marfil, S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115498 · Cited by 7

Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization

Bertoletti, A., Bert, N. L., & Tan, A. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810679 · Cited by 6

Comparison of the Disease Severity and Outcome of Vaccinated COVID-19 Patients with Unvaccinated Patients in a Specialized COVID-19 Facility: A Retrospective Cohort Study from Karachi, Pakistan

Sayeed, M. A., Shalim, E., Farooqui, F., Farman, S., Khan, M., Iqbal, A., Ahmed, I., Rajput, A. W., Razzaque, A., & Quraishy, S. (2023) · Vaccines · doi:10.3390/vaccines11071178 · Cited by 6

Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection

Goto, T., Chong, Y., Tani, N., Susai, N., Yoshinaga, T., Sasaki, T., Taniguchi, M., Kusakabe, T., Shimono, N., Akashi, K., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.10.035 · Cited by 6

Impact of Prior Infection on SARS-CoV-2 Antibody Responses in Vaccinated Long-Term Care Facility Staff

Gallichotte, E. N., Nehring, M., Stromberg, S., Young, M. C., Snell, A., Daniels, J., Pabilonia, K. L., VandeWoude, S., Ehrhart, N. P., & Ebel, G. D. (2022) · mSphere · doi:10.1128/msphere.00169-22 · Cited by 7

Humoral and Memory B Cell Responses Following SARS-CoV-2 Infection and mRNA Vaccination

Bozhkova, M., Raycheva, R., Petrov, S., Dudova, D., Kalfova, T., Murdjeva, M., Taskov, H. B., & Shivarov, V. S. (2025) · Vaccines · doi:10.3390/vaccines13080799 · Cited by 5

Development of Methods to Produce SARS CoV‐2 Virus‐Like Particles at Scale

Edeling, M. A., Earnest, L., Montoya, J. C., Yap, A. H. Y., Mumford, J., Roberts, J., Wong, C. Y., Hans, D., Grima, J., Bisset, N., et al. (2025) · Biotechnology and Bioengineering · doi:10.1002/bit.28937 · Cited by 5

The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients

Yang, L., Xiang, F., Wang, D., Guo, Q., Deng, B., Jiang, D., & Ren, H. (2023) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-023-04566-0 · Cited by 5

Adaptive immune response to BNT162b2 mRNA vaccine in immunocompromised adolescent patients

Bader, G., Itan, M., Edry‐Botzer, L., Cohen, H., Haskin, O., Mozer‐Glassberg, Y., Harel, L., Munitz, A., Marcus, N., & Gerlic, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1131965 · Cited by 5

Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2–inactivated vaccine

He, X., Cao, Y., Lu, Y., Qi, F., Wang, H., Liao, X., Xu, G., Yang, B., Ma, J., Li, D., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1181121 · Cited by 5

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer

Li, T., Song, R., Wang, J., Zhang, J., Cai, H., He, H., Hu, W., Yu, D., Wang, C., Pan, Q., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.07.050 · Cited by 5

Airway and Systemic Immune Responses Following the Third COVID-19 Vaccination in COPD Patients

Southworth, T. W., Jackson, N. A., & Singh, D. (2023) · International Journal of COPD · doi:10.2147/copd.s433269 · Cited by 5

Ad5-nCoV Vaccination Could Induce HLA-E Restricted CD8+ T Cell Responses Specific for Epitopes on Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein

Wang, Y., Yang, L., Tang, K., Zhang, Y., Zhang, C., Zhang, Y., Jin, B., Zhang, Y., Zhuang, R., & Ma, Y. (2023) · Viruses · doi:10.3390/v16010052 · Cited by 5

Immunological memory in infected & exposure näive individuals one year post SARS-CoV-2 vaccination

Das, P., Varun, C. N., Ashwini, M. A., Kesavan, M., Ravi, V., & Desai, A. S. (2025) · The Indian Journal of Medical Research · doi:10.25259/ijmr_923_2024 · Cited by 4

COVID-19 infection and vaccination in immunodeficiency

Mortari, E. P., & Pulvirenti, F. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac080 · Cited by 4

Immune responses to inactivated COVID-19 vaccine were decreased in Chinese patients with chronic respiratory diseases

Yang, L., Xu, L., Guo, Q., Deng, B., Hong, Y., Wang, L., Wang, Y., Jiang, D., & Ren, H. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.78766 · Cited by 3

Receptor-Binding-Domain-Specific B Cell Responses Induced by mRNA Immunization against SARS-CoV-2

Geropeppa, M., Papadatou, I., Sarantis, P., Tzanoudaki, M., Ntanasis‐Stathopoulos, I., Bagratuni, T., Terpos, E., & Spoulou, V. I. (2023) · Vaccines · doi:10.3390/vaccines11071148 · Cited by 3

Antibody immunotherapies for personalized opioid addiction treatment

Rosenn, E. H., Korlansky, M., Benyaminpour, S., Munarova, V., Fox, E., Shah, D., Durham, A., Less, N., & Pasinetti, G. M. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103522 · Cited by 3

Single-Cell RNA Sequencing of Baseline Immune Profiles After Third Vaccination Associated with Subsequent SARS-CoV-2 Infection in Naïve Individuals

Kang, H., Park, J., Bae, H., Chung, Y., & Oh, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083494 · Cited by 3

Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure

Stefanski, A., Rincón-Arévalo, H., Schrezenmeier, E. V., Karberg, K., Szelinski, F., Ritter, J., Chen, Y., Meisel, C., Jahrsdörfer, B., Ludwig, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.943476 · Cited by 5

Measles Virus-Based Vaccine Expressing Membrane-Anchored Spike of SARS-CoV-2 Inducing Efficacious Systemic and Mucosal Humoral Immunity in Hamsters

Yang, Z., Song, Y., Pei, J., Li, S.-Z., Liu, R.-L., Xiong, Y., Wu, J., Liu, Y.-L., Fan, H.-F., Wu, J., et al. (2024) · Viruses · doi:10.3390/v16040559 · Cited by 2

Immune response and associated factors to Hepatitis B vaccination among children under five attending care at mulago hospital

Kimera, A., Rujumba, J., Ndikuno, C. K., Ndeezi, G., Mukiza, N., Basenero, A., Piloya, T., Bakeera‐Kitaka, S., Nabulya, R., Nalumansi, A. M., et al. (2025) · BMC Pediatrics · doi:10.1186/s12887-024-05366-x · Cited by 2

Analysis of humoral and cellular immune activation up to 21 months after heterologous and homologous COVID-19 vaccination

Torre, D. L., Orlandi, C., Conti, I., Barocci, S., Carlotti, E., Magnani, M., Casabianca, A., & Stefanetti, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1579163 · Cited by 2

Investigating the Impact of Peptide-Based Vaccines on Various Types of Cancer: A Systematic Review

Esmaeili, A. (2025) · Cancer Investigation · doi:10.1080/07357907.2025.2568964 · Cited by 2

The role of antigen availability during B cell induction and its effect on sustained memory and antibody production after infection and vaccination—lessons learned from the SARS-CoV-2 pandemic

Bjarnarson, S. P., & Brynjolfsson, S. F. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac113 · Cited by 2

SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience

Pulvirenti, F., Garzi, G., Milito, C., Sculco, E., Sciannamea, M., Napoli, A., Cinti, L., Roberto, P., Punziano, A., Carrabba, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1249462 · Cited by 2

Relationship between B-Cell Populations, Development and Function of B-Cell Subsets

Mortari, E. P., & Carsetti, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95895-0.00022-2 · Cited by 1

Effectiveness of bivalent COVID-19 vaccines against SARS-CoV-2 reinfection in patients with cancer: Evidence from a nationwide target trial emulation

Kim, H.-K., Jo, S., Min, K., & Cho, S. (2026) · Journal of Infection · doi:10.1016/j.jinf.2026.106753 · Cited by 1

Longitudinal humoral and memory B-cell responses to repeated SARS-CoV-2 vaccination in long-term care facilities residents

Palmieri, A., Damiano, C., Leone, P., Sugoni, C., Albano, C., Mortari, E. P., Schiavoni, I., Trevisan, C., Malara, A., Zucchelli, A., et al. (2026) · Immunity & Ageing · doi:10.1186/s12979-026-00581-9 · Cited by 1

COVID-19 vaccination: challenges in the pediatric population

Azoicai, A. N., Miron, I. C., Lupu, A., Alexoae, M. M., Stârcea, I. M., Alecsa, M., Lupu, V. V., Danielescu, C., Nedelcu, A. H., Șalaru, D. L., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1390951 · Cited by 1

Dominant and cross-reactive S1-specific memory B cell response induced by primary SARS-CoV-2 infection

Xing, X., Zhang, Z., Wen, Y., Guo, W., Zhang, X., Min, Y., Zhong, K., Zhang, L., Wei, P., Zhang, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-06847-4 · Cited by 1

The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost

Lima, N. S., McCormick, L., Li, S., Wake, C., Subramanian, R., Spangler, A., Pinto, Y., Catalano, W. L., Henry, A. R., Laboune, F., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aeb9837 · Cited by 1

Olfactory immunity: defending the neural-mucosal barrier

Tracey, S., & Moseman, E. A. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkaf326 · Cited by 1

Short‐Term Promotion of Beneficial Skin Commensal Staphylococcus Species Growth by PS‐B1, a Postbiotic Composed of Lactic Acid Bacteria‐Fermented Soy Milk

Funatsu, O., Ishii, H., Shimatsu, R., Shimokawa, Y., Asahina, A., & Dekio, I. (2026) · Microbiology and Immunology · doi:10.1111/1348-0421.70057 · Cited by 1

Receptor Binding Domain-Specific B Cell Memory Responses Among Individuals Vaccinated Against SARS-CoV-2

Athavale, A., Gaur, A., Ahmed, N., Subramaniam, A., Dandotiya, J., Raj, S., Upadhyay, S. K., Samal, S., Pandey, A. K., Rai, R. C., et al. (2024) · Vaccines · doi:10.3390/vaccines12121396 · Cited by 1

Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine

Wang, X., Yang, X., Zhang, X., Yan, H., Jin, J., Ma, Z., Duan, J., Zhang, G., Huang, T., Li, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1554409 · Cited by 1

Antibody titres in fully vaccinated healthcare workers with and without breakthrough infection during the Delta and Omicron waves

Chandrasingh, S., George, C. E., Inbaraj, L. R., & Maddipati, T. (2023) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1809_22 · Cited by 1

Mucosal delivery of influenza antigens using a replication deficient adenovirus supports broadly reactive antibody responses and heterologous viral immunity in the respiratory tract of animalsPreprint

Schultz, M. D., Botta, D., Silva-Sánchez, A., Cheatwood, I. R., Kalange, D., Terapane, S. M., Lucander, A. C. K., Zhou, F., Akther, J., Yang, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.13.682194 · Cited by 1

Waning of Serum Antibodies, But Increase of Protective B-Cell Memory Nine Months After BNT162b2 VaccinationPreprint

Terreri, S., Mortari, E. P., Vinci, M. R., Russo, C., Alteri, C., Albano, C., Linardos, G., Colagrossi, L., Deriu, G., Atti, M. L. C. D., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3956432

Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic

Molinos-Albert, L. M., Rubio, R., Martín-Pérez, C., Pradenas, E., Torres, C., Jiménez, A., Canyelles, M., Vidal, M., Barrios, D., Marfil, S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115498 · Cited by 7

SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies

Mazzoni, A., Vanni, A., Spinicci, M., Lamacchia, G., Kiros, S. T., Rocca, A., Capone, M., Lauria, N. D., Salvati, L., Carnasciali, A., et al. (2022) · Greater South Information System · doi:10.60692/ra38y-2e405

Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination

Fryer, H. A., Hartley, G. E., Edwards, E. S. J., O’Hehir, R. E., & van Zelm, M. C. (2022) · Biochemical Society Transactions · doi:10.1042/bst20220415 · Cited by 16

Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response

Pušnik, J., König, J., Mai, K., Richter, E., Zorn, J., Proksch, H., Schulte, B., Alter, G., & Streeck, H. (2022) · Journal of Virology · doi:10.1128/jvi.00760-22 · Cited by 28